Public ID: PID-GRL48G
Prescription restrictions on new pharmaceuticals in Japan affecting UK exporters and investors
Trade barrier summary
In Japan, restrictions placed on new pharmaceuticals limit prescription periods to 14 days during the first year the pharmaceutical is on the market. This restriction exists even though new pharmaceuticals have gone through approval processes.
UK businesses are concerned that this restriction may limit patient access to innovative medicines. It could also mean that Japanese doctors are less likely to prescribe these pharmaceuticals.
- Pharmaceuticals and biotechnology
13 November 2018
17 December 2020